Agora (NASDAQ:API – Get Free Report) and Cellebrite DI (NASDAQ:CLBT – Get Free Report) are both technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.
Insider and Institutional Ownership
40.4% of Agora shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 14.6% of Agora shares are held by company insiders. Comparatively, 5.7% of Cellebrite DI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Volatility & Risk
Agora has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Agora | 7.23% | 1.96% | 1.52% |
| Cellebrite DI | 11.43% | 15.58% | 8.29% |
Earnings and Valuation
This table compares Agora and Cellebrite DI”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Agora | $151.69 million | 2.42 | $9.53 million | $0.11 | 38.27 |
| Cellebrite DI | $514.29 million | 5.23 | $78.33 million | $0.22 | 49.05 |
Cellebrite DI has higher revenue and earnings than Agora. Agora is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Agora and Cellebrite DI, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Agora | 1 | 1 | 1 | 0 | 2.00 |
| Cellebrite DI | 1 | 0 | 5 | 0 | 2.67 |
Agora currently has a consensus target price of $6.80, indicating a potential upside of 61.52%. Cellebrite DI has a consensus target price of $16.70, indicating a potential upside of 54.77%. Given Agora’s higher probable upside, equities research analysts plainly believe Agora is more favorable than Cellebrite DI.
Summary
Cellebrite DI beats Agora on 12 of the 14 factors compared between the two stocks.
About Agora
Agora, Inc. operates in real-time engagement technology business in the People's Republic of China, the United States, and internationally. The company offers real-time engagement platform-as-a-services providing developers with application programming interfaces to embed real-time voice, video, interactive live-streaming, chat, whiteboard, and artificial intelligence capabilities into their applications. It also provides video and voice calling, interactive live and broadcast streaming, chat, signaling, and interactive whiteboard products; and extensions, such as analytics, recording, AI noise suppression, 3D spatial audio, real-time transcription, and extensions marketplace. In addition, the company offers Application Platforms, including Flexible Classroom, a low-code application Platform as a Service, which combines video, voice, chat, signaling, whiteboard and recording functionalities into an integrated cloud-based solution for education providers; and App Builder, a no-code application platform, designed for developers with little or no coding experience to build their own applications with video conference and live streaming functionalities. It operates through Agora and Shengwang brands. Agora, Inc. was incorporated in 2013 and is headquartered in Santa Clara, California.
About Cellebrite DI
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.
Receive News & Ratings for Agora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agora and related companies with MarketBeat.com's FREE daily email newsletter.
